2014 “Towards an HIV Cure” symposium Melbourne Cure Research and the Community David Evans, Project Inform.

Slides:



Advertisements
Similar presentations
IPEC - Fundação Oswaldo Cruz Rio de Janeiro -Brazil Women and Trials in Low and Middle-income settings: the clinical investigators Perspective August 6,
Advertisements

TB/HIV Research Priorities: TB Preventive Therapy.
TOWARDS UNIVERSAL ACCESS
Washington D.C., USA, July 2012www.aids2012.org CURE: The point of view of people living with HIV Fred Verdult Amsterdam, The Netherlands Your logo.
OUR FOCUS: UN POLITICAL DECLARATION TARGET No. 4.
Research activities in Orange Farm Bertran Auvert INSERM University of Versailles, France Country update meeting on scaling - up of male circumcision programmes.
The HPTN 052 HIV Treatment as Prevention Trial: A case study of ethical considerations in human research conducted in low and middle income countries (LMIC)
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
HIV/AIDS Major effects on women and children in developing countries.
Fast-track to ending AIDS in Zimbabwe: opportunities
Access to ARVs : good news bad news David Henry WHO Collaborating Centre for Rational Use of Drugs The University of Newcastle NSW.
Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.
The Global Response to AIDS: Does It Pass the Test for Women? Peter Piot Institute for Global Health Imperial College.
GAP Report 2014 People left behind: Gay men and other men who have sex with men Link with the pdf, Gay men and other men who have sex with men.
A Health Based Approach Within The UN Conventions: Examples Of Practice Fay Watson, Vice Chair: EU Civil Society Forum on Drugs.
Effects of patient tracing on estimates of lost to follow-up, mortality and retention in antiretroviral therapy programs in low-middle income countries:
2,100,000 Number of pregnant women with HIV/AIDS 200,000Number of pregnant women receiving PMTCT 630,000Number of MTCT new infections 2,000,000Number of.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
The Overlap of HIV, Key Populations and Psycho-Stimulant drugs CRISTINA PIMENTA, PhD Brazilian Ministry of Health National AIDS Programme Consultant.
"HIV Cure" 101 Workshop Current Community Questions and Concerns about “HIV Cure” Bill Whittaker National Association of People with HIV Australia.
What does PrEP mean for people living with HIV? Edwin J Bernard Co-ordinator, HIV Justice Network Consultant, GNP+
Uptake of antiretrovirals in a cohort of women involved in high risk sexual behaviour in Kampala, Uganda J.Bukenya, M. Kwikiriza, O. Musana, J. Ssensamba,
2014 “Towards an HIV Cure” symposium Melbourne The Role of a Public-Private Partnership in HIV Cure Mike McCune, MD, PhD University of California, San.
Five gay men arrested in Mombasa, Kenya; Mobs call for death by fire Police drag gay man from KEMRI building and arrest him.
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
Improving mental wellbeing in the HIV Community: State of Mind & I Am More Than One Thing Silvia Petretti, Deputy CEO, Positively UK UKCAB 4 July 2014.
July 24, 2012 GENDER ROLES, EQUALITY AND TRANSFORMATIONS PROJECT INSTITUTE FOR REPRODUCTIVE HEALTH GEORGETOWN UNIVERSITY PATHFINDER INTERNATIONAL SAVE.
IAS 2012 feedback: UK Consortium: September 2012 IAS 2012 Feedback: New findings, better drugs and the goal of a cure Simon Collins HIV.
The French National Agency for Research on Aids and Viral Hepatitis – Clinical Research Legislation: A French Experience Ingrid Callies Legal Counsel in.
Center for Health Policy Health Inequalities Program Duke University Beth Stringfield.
OUT-OF-POCKET SPENDING ON TB AND HIV INFECTIONS IN MIDDLE- BELT, NIGERIA BY (1)UMEH, E.U., (2)UMEH, J.C. and (1)UDEH, L. (1)Dept. of Biological Sciences.
Missed opportunities to diagnose TB and HIV Co-infection in HIV workplace program Dr Fred Mugyenyi Asiimwe Medical Director, ALAFA.
ETHICS AND INFORMED CONSENT FOR HIV CURE RESEARCH david evans project inform ETHICS AND INFORMED CONSENT FOR HIV CURE RESEARCH david evans project inform.
GAP Report 2014 People left behind: People aged 50 years and older Link with the pdf, People aged 50 years and older.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Swiss Re – Pandemic Risk Talk Ethical issues in palliative care for patients with M/XDR-TB Geneva, 19 November 2010 Palliative Care and M/XDR-TB meeting.
TREATMENT OF SERO-DISCORDANT COUPLES: IMPLICATIONS FOR YOUNG PEOPLE JJ KUMWENDA (FRCP-UK)
HIV-infected subjects with CD4 350 to 550 cells/mm serodiscordant couples HPTN 052 Study Design Immediate ART CD Delayed ART CD4
Principles and Practices: The implementation of ethical guidelines for research on HIV Geneva, 2-3 June 2003 Ethical guidelines for HIV vaccines: Generic.
FBO Engagement in Male Circumcision May 25, 2009 CCIH Annual Conference.
Engaging Men in the Prevention of Vertical Transmission Shamin Mohamed Jr. Founder | President LetsStopAIDS,
Key Affected Populations in Asia: Where are we and what is the way forward? Dr. Sai Subhasree Raghavan SAATHII, India Governing Council Member, IAS.
Housekeeping Press *7 to mute your line Press *6 to unmute your line For any questions please use the chat function or ask the participants directly by.
Objective 9/23/15 Today we will be completing our research methods unit & begin reviewing for the upcoming unit assessment 9/25. Agenda: -Turn in all homework.
METHODS OF OBSERVATION. SURVEY METHOD Gathering information by asking directly Series of questions on a particular subject ex. voting preferences, shopping,
Perceptions of Discrimination against Gay and Bisexual Men in South Carolina Matthew J. Page, PhD, MPP and Nicole L. Chapman, BS.
Page 1 Social and socio-economic benefits of antiretroviral therapy adherence among HIV-infected people who use illicit drugs in Vancouver, Canada Lindsey.
Community-Level Secondary (Behavioral) Outcomes of NIMH Project Accept (HPTN 043) David D Celentano for the Project Accept Study Team IAS July 2013.
MDG 6: Combat HIV/AIDS and other diseases. Where are we…  Regionally, “on track” for MDG-6 (only a few countries are progressing slowly or show no progress)
What effect would gender equitable education in developing countries have on our world?
HPTN Ethics Guidance for Research: Community Obligations Africa Regional Working Group Meeting, May 19-23, 2003 Lusaka, Zambia.
Leaders in Networking & Knowledge (LINK) II Gay Men’s Health Crisis (GMHC) Kathleen D. Gallagher, MPH Kalyani Sanchez.
Prostate Cancer Symposium An Educational Initiative For Patients, Spouses, Advocates and Healthcare Professionals Importance of Clinical trials Virgil.
Chapter 10 Community and Public Health and Racial/Ethnic Minorities.
The International AIDS Conference is the largest conference on any global health or development issues in the world. First convened during the peak of.
COMMUNITY VIEWS ON BREAST CANCER AND BREAST TISSUE DONATION Rose Ayikukwei ( MPH, Ph.D. ) Senior Technical Advisor, HIV Prevention Elizabeth Glaser Pediatric.
Results: Objective 2 Nicholas C. Heck 1, Lucas A. Mirabito 1, Kelly LeMaire 1, Nicholas A. Livingston 2, and Annesa Flentje 3 Abstract Objective: The present.
HIV Prevention Program for MSM in Post –Conflict Liberia
REINHARD HEUN PROFESSOR OF PSYCHIATRY RADBOURNE UNIT RDH DERBYSHIRE HEALTHCARE FT KEGWORTH, 1 APRIL 2014 What works well in the treatment of psychosis.
Boston University Slideshow Title Goes Here Eliminating CD4 thresholds in South Africa will not lead to large increases in persons receiving ART without.
INTRODUCTION Use 1 slide
Number of people receiving antiretroviral therapy in
Social Marketing for SRH
Treatment Interruptions in HIV Cure-Related Research in the United States: Perceptions, Motivations and Ethical Considerations from Potential HIV-Positive.
Patient Support and Caring for People Living With HIV (PLWHIV)
WHO, UNICEF, UNFPA, UNESCO & GNP+
African perspective on ethical guidelines Salim S Abdool Karim
Commonality of HIV Infection and pregnancy
Keep control: Elite and post-treatment controllers
Presentation transcript:

2014 “Towards an HIV Cure” symposium Melbourne Cure Research and the Community David Evans, Project Inform

What’s been done so far Fred Verdault’s study Gay and bisexual men in the Netherlands Definition of the cure very important: Eliminate future health problems Eliminate risk of reinfection Eliminate risk of transmission Going off of ART less important Study with Nelson Vergel and Michael Arnold Altruism a significant motivator, but… Altruism highest among those seeking a personal benefit from the research

 Community Involvement  ACTG  ANRS  MDC Collaboratories

Limitations  Populations studied  Survey designs  How much do you have to educate in order to conduct a meaningful survey?

Ongoing studies  University of North Carolina study on the ethical dimensions of cure research in Guangzhou and South Africa  ANRS study in France studying psychological and social dimensions of cure research  British study looking at the desirability and willingness to participate in cure research

What does a cure even mean?  Mississippi Baby  Canadian Children  Boston Patients  Visconti Cohort

What does a cure even mean?  How will trials be designed?  What will be the goals of cure research and how will that mesh with the desires of PLWHIV?  What will we call it? Will or should we even use the “C ” word?

Equity in cure research  Will it only be for those who start treatment extremely early or those with cancer?  If we do pediatric research how will we work out the ethics in low income countries?  What should we do about interventions that are likely to be very costly and untransferable to low income countries?

Barriers to participation  Time and timing  No benefit over standard ART  Biological samples  Stigma  Treatment Interruptions/Time off therapy  Time intensity  Risks

What are inducements to participation?  Altruism  Hope for more information about one’s own health (e.g. return of research results)  Hope for benefit  Financial  Treatment Interruption  Reduced infectiousness/vulnerability